EFFECTIVENESS OF CANCER SCREENING PROGRAMS IN EARLY DETECTION AND MORTALITY REDUCTION

Abstract

In this study, the efficacy of popular cancer screening programs will be determined systematically to determine how much they contribute to increasing early detection rates and reducing cause-specific death among different groups of the population.  A mixed-method approach that involves combination of quantitative screening outcomes and qualitative program analyses was used to analyze the data that consisted of mammography, Pap smear, low-dose CT screening, colonoscopy, and PSA-based screening cohort data over a decade.  The findings indicated that screening populations had a 34.6% higher likelihood of discovering stage I-II cancers as opposed to people who were not screened.  A study of death cases revealed that the number of deaths related to cancer decreased significantly: breast cancer cancer deaths reduced by 22.4, cervical cancer deaths by 30.1, colorectal cancer deaths by 18. 7 and lung cancer deaths by 15.9 in individuals who adhered to the recommended screening frequency.  The analysis of the hazard ratios showed that regular screening decreased the risk of mortality by 0.41-0.63 in the different types of cancers.  Qualitative results highlighted increased patient awareness, increased compliance to follow-up, and improved diagnostic efficiency as critical factors contributing to the success of the whole program.  Even with any noteworthy progress, disparities still persisted among the low-income, rural and minority populations due to the lack of convenient access, little knowledge of health and structural barriers.  The researchers determine that the effective cancer screening programs are of great benefit in early diagnosis and reduced fatalities. It also emphasizes that it must be fairly accessible, outreach focused and enhanced integration of the patient-centered follow-up routes to maximize the benefits to all.